Ushbu ish iqtibos qilgan ishlar

82 ta ish

Ish: A REVIEW OF MODERN IMMUNOTHERAPY IN GASTROINTESTINAL MALIGNANT TUMORS

1. Cancer statistics, 2016

   Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal

   MaqolaOAOchiq kirish20167 iqtibos

   ABIABI:AkademIndex/2026.other.189857

2. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

   Dung T. Le, Jennifer N. Uram, Hao Wang +32

   Maqola20155 iqtibos

   ABIABI:AkademIndex/2026.other.630148

3. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

   Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo +13

   Maqola20064 iqtibos

   ABIABI:AkademIndex/2026.other.241896

4. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

   Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer +27

   MaqolaOAOchiq kirish20123 iqtibos

   ABIABI:AkademIndex/2026.other.132162

5. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

   Axel Grothey, Eric Van Cutsem, Alberto Sobrero +17

   Maqola20123 iqtibos

   ABIABI:AkademIndex/2026.other.241897

6. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

   Gordon J. Freeman, Andrew J. Long, Yoshiko Iwai +16

   Maqola20003 iqtibos

   ABIABI:AkademIndex/2026.other.677852

7. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

   Jeong Heo, Tony Reid, Leyo Ruo +23

   MaqolaOAOchiq kirish20132 iqtibos

   ABIABI:AkademIndex/2026.other.047635

8. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

   Bruno Sangro, Carlos Gómez-Martín, Manuel de la Mata +11

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.241866

9. Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer

   Ki Y. Chung, Ira Gore, Lawrence Fong +8

   Maqola20102 iqtibos

   ABIABI:AkademIndex/2026.other.241904

10. The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints

    Nicolás J. Llosa, Michael Cruise, Ada Tam +15

    Maqola20142 iqtibos

    ABIABI:AkademIndex/2026.other.322543

11. Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro +21

    Maqola20082 iqtibos

    ABIABI:AkademIndex/2026.other.548030

12. Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon, Franck Pagès, Francesco M. Marincola +61

    Sharh maqola20122 iqtibos

    ABIABI:AkademIndex/2026.other.620112

13. Immunotherapy and chemotherapy — a practical partnership

    Richard Lake, Bruce Robinson

    Sharh maqola20052 iqtibos

    ABIABI:AkademIndex/2026.other.677837

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677830

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677831

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677832

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677833

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677834

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677835

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677836

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677838

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677839

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677840

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677841

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.677842